PixarBio Corp. has leased an 8,000-sq.-ft. facility in Medford, MA for its new corporate headquarters and research center, which will house chemical, bio, and tissue labs. The company will move its headquarters in Salem, NH to the new facility in Medford and will now have capacity to expand beyond biomaterials for Parkinson’s disease to include biomaterials for epilepsy.
“We are building a home for our world-renowned and award-winning team of researchers to drive innovation and accelerate the development of new treatment options for Parkinson’s disease. We’re confident that our optimized R&D model will generate key intellectual property permitting PixarBio to lead the development of next generation biomaterials for the treatment of Parkinson’s disease as well as a range of chronic neurological conditions,” said chief technology officer Randy Holmes-Farley, Ph.D.
PixarBio Relocates R&D HQ
By Kristin Brooks
Published December 16, 2013
blog comments powered by Disqus